Journals / Pediatric Practice and Research / 2019 / IRUPEC 2019 Kongresi Tam Metin Bildirileri

Sleep-related bruxism response to melatonin treatment: three school age children

Pages
1–4
Publication Date
2019-12-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This case presents three school-aged children who presented with bruxism who responded to low-dose melaton

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Bruxism related to sleep involves activation of the chewing muscles and results in tooth clenching, chattering, and grinding.
📊
Key Findings & Data:Risk factors related to bruxism in sleep are obstructive sleep apnea, alcohol, caffeine, parasomnias such as sleep-talking and sleepwalking, anxiety, and other psychiatric and neurologic disorders, and some medications.
💡
Conclusion & Impact:This case presents three school-aged children who presented with bruxism who responded to low-dose melaton
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:sleep · child · bruxism

Abstract

Bruxism related to sleep involves activation of the chewing muscles and results in tooth clenching, chattering, and grinding. Risk factors related to bruxism in sleep are obstructive sleep apnea, alcohol, caffeine, parasomnias such as sleep-talking and sleepwalking, anxiety, and other psychiatric and neurologic disorders, and some medications. There is still no treatment proven to be effective for the treatment of sleep bruxism. This case presents three school-aged children who presented with bruxism who responded to low-dose melaton

🔖

Cite This Article

ERDEN, S. (2019). Sleep-related bruxism response to melatonin treatment: three school age children. Pediatric Practice and Research, IRUPEC 2019 Kongresi Tam Metin Bildirileri, 1–4. https://ajindex.com/articles/795402

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Referanslar 1. American Academy of Sleep Medicine (2005). Diagnostic and Coding Manual 51-55. 2. Guaita M, Hogl B. Current Treatments of Bruxism. Curr Treat Options Neurol. 2016;18(2):10. 3. Lobbezoo F, van der Zaag J, van Selms MK, et al. Principles for the management of bruxism. J Oral Rehabil. 2008;35(7):509-23. 4. Shulman J. Teaching patients how to stop bruxing habits. J Am Dent Assoc. 2001;132(9):1275-7. 5. Jadidi F, Castrillon E, Svensson P. Effect of conditioning electrical stimuli on temporalis electromyographic activity during sleep. J Oral Rehabil. 2008;35(3):171-83. 6. Ommerborn MA, Schneider C, Giraki M, et al. Effects of an occlusal splint compared with cognitive-behavioral treatment on sleep bruxism activity. Eur J Oral Sci. 2007;115(1):7-14. 7. Falisi G, Rastelli C, Panti F, et al. Psychotropic drugs and bruxism. Expert Opin Drug Saf. 2014;13(10):1319-26. 8. Milosevic A, Agrawal N, Redfearn P, et al. The occurrence of toothwear in users of Ecstasy (3,4-methylenedioxymethamphetamine). Community Dent Oral Epidemiol. 1999;27(4):283-7. 9. Uca AU, Uguz F, Kozak HH, et al. Antidepressant-Induced Sleep Bruxism: Prevalence, Incidence, and Related Factors. Clin Neuropharmacol. 2015;38(6):227-30. 10. Lavigne GJ, Huynh N, Kato T, et al. Genesis of sleep bruxism: motor and autonomic-cardiac interactions. 2007;52(4):381-4. 11. Saletu A, Parapatics S, Anderer P, et al. Controlled clinical, polysomnographic and psychometric studies on differences between sleep bruxers and controls and acute effects of clonazepam as compared with placebo. Eur Arch Psychiatry Clin Neurosci. 2010;260(2):163-74. 12. Bostwick JM, Jaffee MS. Buspirone as an antidote to SSRI-induced bruxism in 4 cases. J Clin Psychiatry. 1999;60(12):857-60. 13. Albayrak Y, Ekinci O. Duloxetine-induced nocturnal bruxism resolved by buspirone: case report. Clin Neuropharmacol. 2011;34(4):137-8. 14. Boeve BF, Silber MH, Ferman TJ. Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med. 2003;4(4):281-4.